This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
LyondellBasell (LYB) Announces 7% Hike in Quarterly Dividend
by Zacks Equity Research
With this hike, LyondellBasell (LYB) will increase its dividend for the 14th consecutive year in 2024.
DuPont's (DD) Tedlar Features Aerospace Innovations at AIX 2024
by Zacks Equity Research
DuPont???s (DD) Tedlar is a significantly lightweight and durable protective material.
3 Top Dividend Aristocrats to Ride Out Summertime Blues
by Tirthankar Chakraborty
With things looking dicey for the stock market in the summer months, it's prudent to invest in Atmos Energy (ATO), Ecolab (ECL) and Walmart (WMT) for their risk-adjusted returns.
B2Gold (BTG) Gains From Focus on Mine Growth Amid Cost Woes
by Zacks Equity Research
B2Gold's (BTG) results have been gaining from its ongoing strategy of maximizing profitable mine production. However, elevated costs are denting margins.
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
by Zacks Equity Research
Investors are optimistic about ResMed (RMD) led by strong growth in the U.S. mask and accessories business and its cloud-connected platforms.
U.S. Steel (X) Launches $150M Pellet Production Facility
by Zacks Equity Research
U.S. Steel (X) launches a $150 million DR-grade pellet production facility at the Keetac Plant in Minnesota, creating jobs and enhancing market adaptability.
Inari Medical (NARI) Sues Truvic on Patent Infringement
by Zacks Equity Research
Inari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary Truvic over intentionally copying and overlapping the designs of Inari Medical's products.
Westlake (WLK) Announces Investment to Manufacture PVCO Pipe
by Zacks Equity Research
This investment will increase Westlake's (WLK) product offering by expanding PVCO pipe manufacturing.
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
by Zacks Equity Research
Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Integer Holdings (ITGR) Gains 23.6% YTD: What's Driving the Stock?
by Zacks Equity Research
Integer Holdings (ITGR) shares soar on the back of growth in the Medical segment. However, fluctuations in raw material prices and the oil and energy market are concerning.
Stereotaxis' (STXS) RMN System to Aid in Treating Arrhythmias
by Zacks Equity Research
Stereotaxis (STXS) announces the completion of treatment of first heart rhythm patients with its Genesis Robotic Magnetic Navigation system in Southern Italy.
Air Products (APD) Invests $70M in St. Louis Facility Expansion
by Zacks Equity Research
Air Products (APD) invests $70M in St. Louis facility expansion, meeting rising demand for clean energy solutions and bolstering local employment.
PPG Invests $300M in New Manufacturing Plant & Facility Upgrades
by Zacks Equity Research
PPG Industries (PPG) announced a $300-million investment to build a new manufacturing plant in Tennessee and enhance other North American facilities.
DOW Expands SAS Chemicals Capacity to Boost Sealant Range
by Zacks Equity Research
DOW owns a minority stake in SAS Chemicals GmbH, which manufactures and provides adhesives and sealants for insulating glass windows.
Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now
by Zacks Equity Research
Ecolab's (ECL) focus on research and development raises optimism about the stock.
DuPont (DD) Announces Plan to Separate Into Three Companies
by Zacks Equity Research
DuPont (DD) to split into three companies, New DuPont, Electronics and Water, enhancing focus and shareholders' value, backed by strong financials and growth projections.
ArcelorMittal (MT) and Partners Test CO2 Capture Technology
by Zacks Equity Research
ArcelorMittal (MT) and partners launch a pilot carbon capture unit in Gent, Belgium, to test and scale CO2 emission reduction technologies.
Fortuna Silver's (FSM) Yaramoko Hits 1M Ounce Gold Milestone
by Zacks Equity Research
Fortuna Silver's (FSM) Yaramoko mine achieves 1 million ounces of gold production.
Here's Why You Should Retain Inari Medical (NARI) for Now
by Zacks Equity Research
Inari Medical (NARI) continues to gain from its expanded product portfolio. However, continued loss at the operating level raises concern.
DOW Starts Commercial Operations of Adhesive & Gap Filler
by Zacks Equity Research
DOW will increase the capacity of its VORATRON Polyurethane Systems product line, ensuring that it can fulfill the rising demand for these materials in battery assembly solutions for e-mobility.
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
by Zacks Equity Research
Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
by Zacks Equity Research
Merit Medical's (MMSI) latest offering is likely to create an efficient approach to inflation, thereby providing improved patient care.
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
by Zacks Equity Research
AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
Southern Copper (SCCO) to Gain From Higher Production & Prices
by Zacks Equity Research
Southern Copper (SCCO) is poised to grow on the back of its existing copper reserves, solid growth projects and recent pickup in copper prices.
Reasons to Add HealthEquity (HQY) Stock to Your Portfolio
by Zacks Equity Research
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.